टाइप 1 डायबिटीज के रोगियों के लिए आशाजनक इम्यूनोलॉजिकल उपचार

टाइप 1 डायबिटीज के रोगियों के लिए आशाजनक इम्यूनोलॉजिकल उपचार: Lessons from the past emphasize adapting protocols: start interventions at diagnosis or pre-clinically in at-risk individuals (identified via autoantibodies). Combination therapies are emerging as a solution, pairing short-term β-cell protectors (e.g., anti-inflammatories) with long-term modulators (e.g., anti-CD3 plus autoantigens). Biomarkers for efficacy—such as Treg frequencies, autoantibody titers, or immune profiling—will enable personalized medicine. The field